Proteome Sciences plc (PMSNF)

Market Cap	8.38M -48.1%
Revenue (ttm)	6.20M +12.2%
Net Income	-4.57M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	14,615
Open	0.0383
Previous Close	0.0133
Day's Range	0.0383 - 0.0383
52-Week Range	0.0133 - 0.0785
Beta	0.24
RSI	49.21
Earnings Date	Apr 2, 2026

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling p...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1993
• Employees: 36
• Stock Exchange: OTCMKTS
• Ticker Symbol: PMSNF

Financial Performance

In 2024, Proteome Sciences's revenue was 4.89 million, a decrease of -2.80% compared to the previous year's 5.03 million. Losses were -3.41 million, 39.4% more than in 2023.

Financial numbers in GBP